Literature DB >> 11916175

A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy.

J Kacmar1, E Cheh, A Montagno, J F Peipert.   

Abstract

OBJECTIVE: To compare the compliance, side effects and efficacy of amoxicillin and azithromycin for the treatment of Chlamydia trachomatis infection in pregnancy.
METHODS: This is a randomized single-blind trial of women diagnosed with C. trachomatis before 33 weeks gestation. Women were randomlyassigned either 500 mg amoxicillin orally three times per dayfor 7 days or a single dose of 1 g azithromycin orally. Patients were interviewed by telephone approximately 3-7 days following therapy to assess compliance and side effects. Test of cure was performed at a follow-up visit 4-6 weeks following completion of therapy.
RESULTS: Thirty-nine patients were randomized with 19 receiving amoxicillin and 20 receiving azithromycin. There were no differences in baseline data between the two groups, and there were no statistically significant differences in side effects, compliance or efficacy. In the amoxicillin group 84% of women took all pills, while 100% completed the single 1 g dose of azithromycin. Side effects were common in both groups (38% overall), with 40% of the azithromycin group reporting moderate to severe gastrointestinal side effects compared to 17% in the amoxicillin group (p = 0.11). Of patients who returned for follow-up test of cure, 3 of 15 (20%) in the amoxicillin group were positive compared with 1 of 19 (5%) in the azithromycin group (p = 0.3).
CONCLUSIONS: Side effects of therapy for C. trachomatis in pregnancy are common. Amoxicillin was slightly better tolerated than azithromycin. Compliance and cure rates with both regimens was high.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11916175      PMCID: PMC1784654          DOI: 10.1155/S1064744901000321

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  11 in total

1.  Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin.

Authors:  C D Adair; M Gunter; T G Stovall; G McElroy; J C Veille; J M Ernest
Journal:  Obstet Gynecol       Date:  1998-02       Impact factor: 7.661

2.  A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy.

Authors:  G F Jacobson; A M Autry; R S Kirby; E M Liverman; R U Motley
Journal:  Am J Obstet Gynecol       Date:  2001-06       Impact factor: 8.661

3.  A decision analysis to guide antibiotic selection for Chlamydia infection during pregnancy.

Authors:  W J Hueston; J G Lenhart
Journal:  Arch Fam Med       Date:  1997 Nov-Dec

4.  Treatment of Chlamydia trachomatis infections in pregnant women.

Authors:  J M Miller; D H Martin
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

5.  Double-blind randomized study comparing amoxicillin and erythromycin for the treatment of Chlamydia trachomatis in pregnancy.

Authors:  A H Magat; L S Alger; D A Nagey; V Hatch; J C Lovchik
Journal:  Obstet Gynecol       Date:  1993-05       Impact factor: 7.661

6.  Single-dose azithromycin for Chlamydia in pregnant women.

Authors:  H A Wehbeh; R M Ruggeirio; S Shahem; G Lopez; Y Ali
Journal:  J Reprod Med       Date:  1998-06       Impact factor: 0.142

7.  Amoxicillin therapy for Chlamydia trachomatis in pregnancy.

Authors:  W R Crombleholme; J Schachter; M Grossman; D V Landers; R L Sweet
Journal:  Obstet Gynecol       Date:  1990-05       Impact factor: 7.661

8.  A randomized, prospective trial comparing amoxicillin and erythromycin for the treatment of Chlamydia trachomatis in pregnancy.

Authors:  N S Silverman; M Sullivan; M Hochman; M Womack; D L Jungkind
Journal:  Am J Obstet Gynecol       Date:  1994-03       Impact factor: 8.661

9.  Azithromycin and erythromycin in the treatment of cervical chlamydial infection during pregnancy.

Authors:  M R Bush; C Rosa
Journal:  Obstet Gynecol       Date:  1994-07       Impact factor: 7.661

10.  Assessment of office-based care of sexually transmitted diseases and vaginitis and antibiotic decision-making by obstetrician-gynecologists.

Authors:  J A McGregor; W D Hager; R S Gibbs; L Schmidt; J Schulkin
Journal:  Infect Dis Obstet Gynecol       Date:  1998
View more
  13 in total

1.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

2.  STATEMENT ON PREGNANCY AND TRAVEL: Committee to Advise on Tropical Medicine and Travel.

Authors:  C Beallor
Journal:  Can Commun Dis Rep       Date:  2010-03-08

Review 3.  Interventions for treating genital chlamydia trachomatis infection in pregnancy.

Authors:  P Brocklehurst; G Rooney
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 4.  Chlamydia (uncomplicated, genital).

Authors:  Paddy Horner
Journal:  BMJ Clin Evid       Date:  2010-04-22

Review 5.  Chlamydia (uncomplicated, genital).

Authors:  Megan Crofts; Paddy Horner
Journal:  BMJ Clin Evid       Date:  2015-04-16

Review 6.  Chlamydia (uncomplicated, genital).

Authors:  Paddy Horner
Journal:  BMJ Clin Evid       Date:  2008-06-23

Review 7.  Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy.

Authors:  R Matthew Chico; Daniel Chandramohan
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-07-07       Impact factor: 4.481

Review 8.  Urogenital chlamydia trachomatis treatment failure with azithromycin: A meta-analysis.

Authors:  Farnaz Mohammadzadeh; Mahrokh Dolatian; Masoumeh Jorjani; Maryam Afrakhteh; Hamid Alavi Majd; Fatemeh Abdi; Reza Pakzad
Journal:  Int J Reprod Biomed       Date:  2019-09-22

9.  Penicillin kills Chlamydia following the fusion of bacteria with lysosomes and prevents genital inflammatory lesions in C. muridarum-infected mice.

Authors:  Maud Dumoux; Sylvain M Le Gall; Mohamed Habbeddine; Christiane Delarbre; Richard D Hayward; Colette Kanellopoulos-Langevin; Philippe Verbeke
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 10.  On the pathway to better birth outcomes? A systematic review of azithromycin and curable sexually transmitted infections.

Authors:  R Matthew Chico; Berkin B Hack; Melanie J Newport; Enesia Ngulube; Daniel Chandramohan
Journal:  Expert Rev Anti Infect Ther       Date:  2013-11-06       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.